Neutrophil count in small-for-gestational age children: Contrasting effects of metformin and growth hormone therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3435-3439

  Ibáñez, Lourdes ^a   Fucci, Alina ^a   Valls, Carme ^a   Ong, Ken ^b   Dunger, David ^b   De Zegher, Francis ^c,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d FUND FOR SCIENTIFIC RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HUMAN GROWTH HORMONE; INTERLEUKIN 6; METFORMIN; PRASTERONE SULFATE;

ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; LEUKOCYTE COUNT; MALE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT STATURE; SMALL FOR DATE INFANT; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG EFFECT; NEUTROPHIL; NEWBORN; PHYSIOLOGY; REFERENCE VALUE;

CHILD; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LEUKOCYTE COUNT; METFORMIN; NEUTROPHILS; REFERENCE VALUES;

EID: 21244466417     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0049     Document Type: Article

References (39)

1. Hokken-Koelega A, De Ridder M, Lemmen R, Den Hartog H, de Muinck Keizer-Schrama SMPF 1995 Children born small for gestational age: do they catch-up? Pediatr Res 38:267-271
2. Karlberg J, Albertsson-Wikland K 1995 Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 38:733-739
3. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniguez G, Ong KK, Dunger DB, Mericq MV 2003 Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 88:3645-3650
4. Francois I, de Zegher F 1997 Adrenarche and fetal growth. Pediatr Res 41:440-442
5. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A 1997 Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 82:2283-2288
6. Ibáñez L, Potau N, Francois I, de Zegher F 1998 Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83:3558-3562
7. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA 2002 Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 87:4657-4661
8. Ibáñ L, Ong K, Mongan N, Jaäskelainen J, Marcos MV, Hughes I, de Zegher F, Dunger DB 2003 Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 88:3333-3338
9. Ong K, Potau N, Petry CJ, Ness AR, Jones R, the ALSPAC Study Team, Honour JW, de Zegher F, Ibáñz, Dunger DB 2004 Adrenarche is paradoxically modulated by prenatal and postnatal weight gain. J Clin Endocrinol Metab 89:2647-2651
10. Ibáñz L, Valls C, Marcos MV, Ong K, Dunger D, de Zegher F 2004 Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin. J Clin Endocrinol Metab 89:4331-4337
11. de Zegher F, Hokken-Koelega A 2005 Growth hormone therapy in children born small for gestational age: height gain over the long term is less dosedependent than over the short term. Pediatrics 115:458-462
12. de Zegher F, Ong K, van Helvoirt M, Mohn A, Woods K, Dunger D 2002 High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatmentGH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab 87:148-151
13. van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 2003 Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age. J Clin Endocrinol Metab 88:347-353
14. Battaglia FC, Lubchenko MO 1967 A practical classification of newborn infants by weight and gestational age. J Pediatr 71:159-163
15. Tanner JM, Whitehouse RH, Takaishi M 1986 Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965 part II. Arch Dis Child 41:613-635
16. de la Puente ML, Canela J, Alvarez J, Salleras L, Vicens-Calvet E 1997 Cross-sectional study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol 24:435-452
17. Marshall WA, Tanner JM 1969 Variations in the pattern of pubertal changes in girls. Arch Dis Child 44:291-303
18. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
19. Ducharme JR, Forest M, de Peretti E, SempSempé M, Collu R, Bertrand J 1976 Plasma adrenal and gonadal sex steroids in human pubertal development. J Clin Endocrinol Metab 42:468-476
20. Levy JC, Matthews DR, Hermans MP 1998 Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192
21. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD 1997 Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 82:402-406
22. Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M; Reeser M, Hokken-Koelega A 2001 Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol 54:243-251
23. Woods KA, Van Helvoirt M, Ong KKL, Mohn A, Levy J, de Zegher F, Dunger DB 2001 The somatotropic axis in short children born small for gestational age: relation to insulin resistance. Pediatr Res 51:76-80
24. Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, Pontiroli AE 1999 Mediation of the hepatic effects of growth hormone by its lipolytic activity. J Clin Endocrinol Metab 84:1658-1663
25. Pittas AG, Joseph NA, Greenberg AS 2004 Hot topic: adipocytokines and insulin resistance. J Clin Endocrinol Metab 89:447-455
26. Orio Jr F, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanova' L, Nardo LG, Labella D, Savastano S, Russo T, Zullo F, Colao A, Lombardi G 2005 The increase of leukocytes as a new putative marker of low grade chronic inflammation and early cardiovascular risk in the polycystic ovary syndrome. J Clin Endocrinol Metab 90:2-5
27. Ibáñez L, Jaramillo A, Ferrer A, de Zegher F, High neutrophil count in girls and women with hyperinsulinemic hyperandrogenism: normalization with metformin and flutamide overcomes aggravation by oral contraception. Hum Reprod, in press
28. Cianfarani S, Martinez C, Maiorana A, Scirè G, Spadoni GL, Boemi S 2004 Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth. J Clin Endocrinol Metab 89:1346-1351
29. Kappel M, Hansen MB, Diamant M, Pedersen BK 1994 In vitro effects of human growth hormone on the proliferative responses and cytokine production of blood mononuclear cells. Horm Metab Res 26:612-614
30. Hansen TK, Thiel S, Dall R, Rosenfalck AM, Trainer P, Flyvbjerg A, Jorgensen JOL, Christiansen JS 2001 GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab 86:5383-5388
31. Gravholt CH, Leth-Larsen R, Lauridsen AL, Thiel S, Hansen TK, Holmskov U, Naeraa RW, Christiansen JS 2004 The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. Eur J Endocrinol 150:355-362
32. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ 1999 Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785-792
33. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE 2001 The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
34. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH 2000 Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772
35. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, PfeifferAFH2003 Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228
36. Goldstein BJ, Scalia R 2004 Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89:2563-2568
37. Boonstra VH, Mulder PGH, de Jong FH, Hokken-Koelega ACS 2004 Serum dehydroepiandrosterone sulfate levels and pubarche in short children born small for gestational age before and during growth hormone treatment. J Clin Endocrinol Metab 89:712-717
38. Boonstra V, van Pareren Y, Mulder P, Hokken-Koelega, A 2003 Puberty in growth hormone-treated children born small for gestational age (SGA). J Clin Endocrinol Metab 88:5753-5758
39. Ibáñez L, Ferrer A, Ong K, Amin R, Dunger D, de Zegher F 2004 Insulin sensitization early post-menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr 144:23-29